CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record
Meeting Coverage > IKCS — Confirmed responses in one-fourth to one-third of patients with refractory disease by Charles Bankhead, Senior...
Meeting Coverage > IKCS — Confirmed responses in one-fourth to one-third of patients with refractory disease by Charles Bankhead, Senior...